Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-069824
Filing Date
2025-05-13
Accepted
2025-05-13 08:14:38
Documents
54
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q coya-20250331.htm   iXBRL 10-Q 1352028
2 EX-31.1 coya-ex31_1.htm EX-31.1 15350
3 EX-31.2 coya-ex31_2.htm EX-31.2 14939
4 EX-32.1 coya-ex32_1.htm EX-32.1 15067
  Complete submission text file 0000950170-25-069824.txt   6488760

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT coya-20250331.xsd EX-101.SCH 982590
56 EXTRACTED XBRL INSTANCE DOCUMENT coya-20250331_htm.xml XML 1193061
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41583 | Film No.: 25937281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)